Cancer Surgery Research at Peter Mac
Led by Prof Alexander Heriot, covers a broad spectrum of surgical management of cancer. This includes a significant integrated translational program, bridging basic science ‘bench’ research to the ‘bedside’ of the patient, exploring the molecular biology of specific tumours with prediction and prognosis, and development of novel therapies. Evaluation of outcomes after surgical management and integration with multidisciplinary management is core to the research program, and this supports a strong clinical trials program.
Junior medical staff are encouraged to participate in the research activities of the Division and have the opportunity to undertake their own supervised research using clinical material sourced from the databases.
Cancer surgery researchers facilitate clinical trials, and research is conducted in collaboration with laboratory-based programs in basic oncological science.
The Cancer Anaesthesia, Pain and Perioperative Medicine research team
Led by A/Prof Bernhard Riedel, the team seeks to ensure novel strategies that ensure optimal patient outcomes following cancer surgery. The research profile includes pre-surgical risk stratification, including cardiopulmonary exercise testing, multimodal prehabilitation programs to get patients fit for surgery, novel anaesthetic techniques to offset the surgical stress response, and effective post-operative pain control and prevention of persistent pain. Utilising enhanced recovery techniques and reducing postoperative complication rates will allow patients to return to their cancer journey, including adjuvant therapies.
Surgery and anaesthesia research at Peter Mac is conducted across a number of cancer types:
- Head and neck
- Upper gastrointestinal
- Skin (melanoma)